PROCF
Sofgen Pharma S.A.
$0.03
+0.00 (+0.00%)
At close · Jul 8
Market Cap
$58.41M
Shares
2,327,240,312
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-18 | Bernal Jaramillo Daniel Augusto |
Director |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Romero Camacho Carlos |
Director |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Weinstein Nicolas Alexandre |
Director |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Vial Claro Manuel Jose |
Director |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Palacios Luis Alberto |
Chief Commercial Officer |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Silva Angelini Melissa Andreia |
Interim CEO |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Garcia Iragorri Carlos |
Director |
Other
|
No Securities Owned
|
0 |
| 2026-03-18 | Eguiguren Alberto |
Director |
Other
|
No Securities Owned
|
0 |
Showing 1–8 of 8 transactions